Clobazam Suspension
Product Images NDC 16714-087

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 16714-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
Clobazam Oral Suspension is a medication used for oral administration only. Each mL contains 25 mg of clobazam. It is supplied with two 10 mL oral syringes for administration. It should be shaken well before each use and should be used within 90 days of first opening, after which any remainder should be discarded. The oral suspension should be stored and dispensed in its original container upright, and the pharmacist should dispense the medication guide provided separately to each patient. The usual dosage and other necessary information are available in the package insert. Northstar Rx LLC manufactures this oral suspension medication in Memphis, TN 38141, and it is manufactured by Hetero Labs Limited in Hyderabad, India.*
FDA Label Image

Containerlabel (Containerlabel)

Containerlabel (Containerlabel)
Clobazam Oral Suspension is a medication that should be administered orally as it contains 2.5 mg of clobazam per ml of the solution. To get the full prescribing information, the usual dosage should be verified by referring to the package insert. The bottle's content can be used within 90 days after opening, and it must be kept in the original container and upright at 20°C to 25°C (68°F to 77°F) temperature, which complies with USP Controlled Room Temperature. Before use, shake the bottle correctly. Each patient must be provided with a Medication Guide for more information. For any queries, the customer may visit northstarrxlic.com/products or may call 1-800-206-7821. The details of manufacture by Hetero Labs Limited, Jeedimetla, Hyderabad, India, and manufacturing for Northstar Rx LLC, Memphis, TN38141, are also mentioned.*
FDA Label Image

Figure--a (Figure A)

Figure--a (Figure A)
FDA Label Image

Figure--i (Figure I)

Figure--i (Figure I)
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
This text is too short to provide any meaningful description. It is a common instruction to shake a container, but without additional context, it is not possible to draw any conclusions or provide further details.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
FDA Label Image

Figure-g (Figure G)

Figure-g (Figure G)
FDA Label Image

Figure-h (Figure H)

Figure-h (Figure H)
FDA Label Image

Graph (Graph)

Graph (Graph)
FDA Label Image

Graph2 (Graph2)

Graph2 (Graph2)
The text seems to be a graph or visual representation of data related to the medication Clobazam and its effects on drop seizures. Therefore, a description cannot be generated with high accuracy.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.